Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 10 OCTOBER 2017

Cyprus Section Of Mifid II Report 2017

Elias Neocleous & Co LLC
Elias Neocleous & Co LLC
Contributor
Elias Neocleous & Co LLC

Elias Neocleous & Co LLC

Elias Neocleous & Co LLC (ENC) is among the largest firms in southeast Europe and the Eastern...

View firm profile
Explore more from Elias Neocleous & Co LLC

There are currently more than 250 investment firms authorised by the Cyprus Securities and Exchange Commission (Cysec) operating in or from Cyprus.

CyprusWealth Management
Elias Neocleous & Co LLC
Elias Neocleous & Co LLC
Author LinkedIn connections

SECTION 1: Market outlook

1.1 Please clarify which products or markets your jurisdiction hosts that are affected by Mifid II.

There are currently more than 250 investment firms authorised by the Cyprus Securities and Exchange Commission (Cysec) operating in or from Cyprus. The financial instruments they deal in include contracts for difference, binary options and other speculative forex products, in a number of jurisdictions, either in the EU or in third countries to the extent permitted by the applicable local legislation.

In addition, as an intermediary holding jurisdiction, Cyprus hosts buy-side entities including private asset holding structures and managers of investment funds. As primary recipients of the investment services of investment firms, they will undoubtedly benefit from the Mifid II provisions on investor protection, market transparency and increased market competition.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

Cyprus Trusts Holding UK Property<br />New UK Registration Requirements From 30 June 2026

New UK regulations effective 30 June 2026 have expanded Trust Registration Service requirements for non-UK trusts holding UK property acquired before 6 October 2020. Cyprus trustees must now navigate complex cross-border compliance obligations, reconcile beneficial ownership reporting across multiple jurisdictions, and understand the critical distinction between direct property ownership and corporate holding structures.
CyprusWealth Management
AGPLAW | A.G. Paphitis & Co. LLC
AGPLAW | A.G. Paphitis & Co. LLC
Article

From Cybersecurity To Supply Chain Sovereignty In CSA2: The Spotlight On Suppliers

In January 2026, the European Commission unveiled its plan to overhaul the EU's Cybersecurity Act, a proposal now known as CSA2. It's the natural next step in a story that began years earlier with the EU's 2020 "5G Security Toolbox" - a set of voluntary recommendations encouraging Member States to be cautious about certain telecom suppliers. That voluntary approach produced patchy results: by most accounts, fewer than half of EU countries had actually acted on those recommendations. It is worth asking whether the adoption levels were however a failure of design, or a reflection of Member States reaching different conclusions about their risk exposures.
CyprusTechnology
Elias Neocleous & Co LLC
Elias Neocleous & Co LLC
Article

Jurisdiction In Cross-border Litigation: Insights From A Recent Cyprus Court Decision

It is not uncommon for high-value commercial disputes to give rise to jurisdictional issues, particularly where they involve multiple defendants domiciled in different jurisdictions or where one or more parties have entered into agreements containing jurisdiction clauses. The reason is straightforward: if the Court determines that it lacks jurisdiction to hear the matter, the proceedings may effectively come to an end at the outset. Accordingly, the issue of jurisdiction must be determined by the Court as a preliminary matter and at the earliest stage of proceedings.
CyprusLitigation, Mediation & Arbitration
Elias Neocleous & Co LLC
Elias Neocleous & Co LLC